Whitney Sealls

796 total citations · 1 hit paper
13 papers, 647 citations indexed

About

Whitney Sealls is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Whitney Sealls has authored 13 papers receiving a total of 647 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Surgery. Recurrent topics in Whitney Sealls's work include Metabolism, Diabetes, and Cancer (6 papers), Peroxisome Proliferator-Activated Receptors (5 papers) and Diabetes Treatment and Management (5 papers). Whitney Sealls is often cited by papers focused on Metabolism, Diabetes, and Cancer (6 papers), Peroxisome Proliferator-Activated Receptors (5 papers) and Diabetes Treatment and Management (5 papers). Whitney Sealls collaborates with scholars based in United States, Mexico and Germany. Whitney Sealls's co-authors include Kathleen Dungan, Jessie L. Fahrbach, Charles Atisso, José Gerardo González‐González, Santiago Tofé, Thomas Först, Paul N. Black, Concetta Dirusso, Jeffrey S. Elmendorf and Kirk M. Habegger and has published in prestigious journals such as The Lancet, Arteriosclerosis Thrombosis and Vascular Biology and Journal of Lipid Research.

In The Last Decade

Whitney Sealls

11 papers receiving 636 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Once-weekly dulaglutide versus once-daily liraglutide in metformin-treated patients with type 2 diabetes (AWARD-6): a randomised, open-label, phase 3, non-inferiority trial

2014 391 citations Kathleen Dungan, Santiago Tofé et al. The Lancet profile →

Peers

Whitney Sealls

EDM

MB

SURGE

PHARM

PHYSI

Valentina Spigoni Italy

Andrew Vick United States

Dustan A. Barber United States

Huanyi Cao China

Yoshiaki Hirashima Japan

Zhiwen Yu China

H.-U. Häring Germany

Maria Dulak‐Lis United Kingdom

Kuanxiao Tang China

A Vrána Czechia

Valentina Spigoni Italy

Whitney Sealls

156 ×0.4

EDM

188 ×0.6

MB

87 ×0.5

SURGE

63 ×0.5

PHARM

108 ×1.2

PHYSI

Citations per year, relative to Whitney Sealls Whitney Sealls (= 1×) peers Valentina Spigoni

Countries citing papers authored by Whitney Sealls

Since Specialization

Citations

This map shows the geographic impact of Whitney Sealls's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Whitney Sealls with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Whitney Sealls more than expected).

Fields of papers citing papers by Whitney Sealls

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Whitney Sealls. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Whitney Sealls. The network helps show where Whitney Sealls may publish in the future.

Co-authorship network of co-authors of Whitney Sealls

This figure shows the co-authorship network connecting the top 25 collaborators of Whitney Sealls. A scholar is included among the top collaborators of Whitney Sealls based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Whitney Sealls. Whitney Sealls is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

1.

Hoogwerf, Byron J., et al.. (2020). Real-World Glycemic Lowering Effectiveness of Linagliptin Among Adults with Type 2 Diabetes by Age, Renal Function, and Race. Diabetes Therapy. 11(7). 1527–1536. 1 indexed citations

2.

Dungan, Kathleen, Itamar Raz, Zachary Skrivanek, Whitney Sealls, & Jessie L. Fahrbach. (2015). Achieving the composite endpoint of glycated haemoglobin <7.0%, no weight gain and no hypoglycaemia in the once‐weekly dulaglutide AWARD programme. Diabetes Obesity and Metabolism. 18(1). 49–55. 16 indexed citations

3.

Hoffman, Nolan J., et al.. (2014). Chromium Enhances Insulin Responsiveness via AMPK. Research Bank (Australian Catholic University). 1 indexed citations

4.

Hoffman, Nolan J., et al.. (2014). Chromium enhances insulin responsiveness via AMPK. The Journal of Nutritional Biochemistry. 25(5). 565–572. 49 indexed citations

5.

Dungan, Kathleen, Santiago Tofé, Thomas Först, et al.. (2014). Once-weekly dulaglutide versus once-daily liraglutide in metformin-treated patients with type 2 diabetes (AWARD-6): a randomised, open-label, phase 3, non-inferiority trial. The Lancet. 384(9951). 1349–1357. 391 indexed citations breakdown →

6.

Dungan, Kathleen, Santiago Tofé, Thomas Först, et al.. (2014). Efficacy and Safety of Once Weekly Dulaglutide vs. Once Daily Liraglutide in Type 2 Diabetes (AWARD 6). Canadian Journal of Diabetes. 38(5). S11–S11.

7.

Habegger, Kirk M., Whitney Sealls, Lixuan Tackett, et al.. (2011). Fat-induced membrane cholesterol accrual provokes cortical filamentous actin destabilisation and glucose transport dysfunction in skeletal muscle. Diabetologia. 55(2). 457–467. 45 indexed citations

8.

Sealls, Whitney, et al.. (2011). Evidence That Chromium Modulates Cellular Cholesterol Homeostasis and ABCA1 Functionality Impaired by Hyperinsulinemia—Brief Report. Arteriosclerosis Thrombosis and Vascular Biology. 31(5). 1139–1140. 17 indexed citations

9.

Sealls, Whitney, et al.. (2010). Evidence that Hyperinsulinemia, known to Accelerate Diabetes Progression, may also Contribute to Dyslipidemia via Impairing ApoA1/ABCA1-Mediated Cholesterol Efflux. IUScholarWorks (Indiana University).

10.

González-Lopez, Monika, Whitney Sealls, Elliot D. Jesch, et al.. (2010). Defining a relationship between dietary fatty acids and the cytochrome P450 system in a mouse model of fatty liver disease. Physiological Genomics. 43(3). 121–135. 14 indexed citations

11.

Fraisl, Peter, et al.. (2008). Fatty acid transport and activation and the expression patterns of genes involved in fatty acid trafficking. Archives of Biochemistry and Biophysics. 477(2). 363–371. 57 indexed citations

12.

Sealls, Whitney, Monika González-Lopez, M. Julia Brosnan, Paul N. Black, & Concetta Dirusso. (2008). Dietary polyunsaturated fatty acids (C18:2 ω6 and C18:3 ω3) do not suppress hepatic lipogenesis. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1781(8). 406–414. 30 indexed citations

13.

Li, Hong, et al.. (2007). High-throughput screening for fatty acid uptake inhibitors in humanized yeast identifies atypical antipsychotic drugs that cause dyslipidemias. Journal of Lipid Research. 49(1). 230–244. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact